1. Home
  2. PBLS vs NATL Comparison

PBLS vs NATL Comparison

Compare PBLS & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$28.42

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$47.39

Market Cap

3.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBLS
NATL
Founded
N/A
2023
Country
United States
United States
Employees
N/A
20000
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.5B
IPO Year
2026
2023

Fundamental Metrics

Financial Performance
Metric
PBLS
NATL
Price
$28.42
$47.39
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$45.60
AVG Volume (30 Days)
545.1K
553.7K
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
73.98
EPS
N/A
0.29
Revenue
N/A
$4,354,000,000.00
Revenue This Year
N/A
$6.13
Revenue Next Year
N/A
$4.24
P/E Ratio
N/A
$162.21
Revenue Growth
N/A
0.86
52 Week Low
$25.56
$23.56
52 Week High
$33.65
$48.50

Technical Indicators

Market Signals
Indicator
PBLS
NATL
Relative Strength Index (RSI) 52.17 79.39
Support Level $26.96 $43.51
Resistance Level $30.90 $48.50
Average True Range (ATR) 2.39 0.63
MACD -0.05 0.36
Stochastic Oscillator 30.56 98.97

Price Performance

Historical Comparison
PBLS
NATL

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

About NATL NCR Atleos Corporation

NCR Atleos Corp is a financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers, and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels, all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware, and its proprietary Allpoint network. Atleos manages its operations in the following segments: Self-Service Banking, which generates maximum revenue, Network, and Telecommunications and Technology. Geographically, it derives maximum revenue from the U.S.

Share on Social Networks: